You are here: Industry Insights > Diabetes

News List

‘OneUp’ trek challenge held for diabetes patients expressbpd
October 13, 2017
Sanofi India, Diabetes India and Aurangabad-based NGO ‘Udaan’ recently organised ‘OneUp’ trek for people suffering from type 1 diabetes (T1D). 23 people suffering from T1D took part in the challenge.
IDF and Novo Nordisk launch first-ever global survey on cardiovascular disease awareness among peopl worldpharmanews
September 30, 2017
(IDF) has partnered with Novo Nordisk to launch the first-ever multi-country online survey investigating the level of CVD awareness and knowledge among people living with type 2 diabetes
Ministry of AYUSH conducts online article writing contests on prevention and management of diabetes expressbpd
September 14, 2017
Special Secretary AYUSH gives away prizes to winners of the contest
Biochemical fingerprints reveal diabetes progression europeanpharmaceuticalreview
August 23, 2017
Researchers have describe a new method to study biochemical changes that occur in the pancreas during the development of diabetes…
Less sleep in children relevant to higher risk of diabetes pharmafile
August 17, 2017
A study emerging from St George’s University of London found that children who slept an hour less than the recommended amount were more likely to have an increased risk of developing type 2 diabetes.
Lexicon Reports Additional Positive Data from Sotagliflozin Pivotal Phase 3 Study pharmaceutical-technology
August 16, 2017
Lexicon Pharmaceuticals announced additional positive data from the pivotal Phase 3 inTandem2 study of sotagliflozin, an investigational dual SGLT1 and SGLT2 inhibitor.
Testing the safety of immunotherapy in diabetes fiercebiotech
August 10, 2017
Some researchers hope immunotherapy will make these tools obsolete in treating diabetes.
Diabetes prescriptions rocket 80 percent in a decade pharmatimes
August 03, 2017
Growth in prescriptions for diabetes medicines is exceeding the rise in overall prescribing, according to new figures from NHS Digital.
EU approves CV benefit claim for Novo’s Victoza pharmatimes
July 31, 2017
Novo Nordisk’s diabetes drug Victoza is now approved in Europe as the only GLP-1 analogue with a label including prevention of cardiovascular events.
Avacen’s innovation expected to dramatically reduce amputations in India biospectrumasia
July 25, 2017
Initial focus will be to reduce the number of limb amputations resulting from foot ulcers, a common complication associated with diabetes.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 37 38 Next page